MSB 3.16% $1.31 mesoblast limited

Entering the PAZ - give us your predictions!, page-182

  1. 6,374 Posts.
    lightbulb Created with Sketch. 379
    Agree Ces…..to read details of ‘despite the demonstrated success from an EAP’
    the company was issued a CLR……..it is a reality check on exactly what we are dealing with. Our BLA journey has been complex & expensive…..laced with ‘good cop bad cop appraisals & regulatory red tape. We are not ‘over the line’ with this despite all of the encouraging data and successful patient outcomes. We should be……but………
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.